Cargando…

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya

BACKGROUND: A few studies have assessed the epidemiological impact and the cost-effectiveness of COVID-19 vaccines in settings where most of the population had been exposed to SARS-CoV-2 infection. METHODS: We conducted a cost-effectiveness analysis of COVID-19 vaccine in Kenya from a societal persp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orangi, Stacey, Ojal, John, Brand, Samuel PC, Orlendo, Cameline, Kairu, Angela, Aziza, Rabia, Ogero, Morris, Agweyu, Ambrose, Warimwe, George M, Uyoga, Sophie, Otieno, Edward, Ochola-Oyier, Lynette I, Agoti, Charles N, Kasera, Kadondi, Amoth, Patrick, Mwangangi, Mercy, Aman, Rashid, Ng'ang'a, Wangari, Adetifa, Ifedayo MO, Scott, J Anthony G, Bejon, Philip, Keeling, Matt J, Flasche, Stefan, Nokes, D James, Barasa, Edwine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344598/ https://www.ncbi.nlm.nih.gov/pubmed/35914832 http://dx.doi.org/10.1136/bmjgh-2022-009430

Ejemplares similares

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
por: Ojal, John, et al.
Publicado: (2022)

COVID-19 transmission dynamics underlying epidemic waves in Kenya
por: Brand, Samuel P. C., et al.
Publicado: (2021)

Indirect health effects of the COVID-19 pandemic in Kenya: a mixed methods assessment
por: Barasa, Edwine, et al.
Publicado: (2021)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2021)

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021
por: Etyang, Anthony O., et al.
Publicado: (2022)

Examining the unit costs of COVID-19 vaccine delivery in Kenya
por: Orangi, Stacey, et al.
Publicado: (2022)

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
por: Lucinde, Ruth K., et al.
Publicado: (2022)

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya
por: Nyagwange, James, et al.
Publicado: (2022)

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
por: Kagucia, E Wangeci, et al.
Publicado: (2021)

Examining unit costs for COVID-19 case management in Kenya
por: Barasa, Edwine, et al.
Publicado: (2021)

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
por: Etyang, Anthony O, et al.
Publicado: (2021)

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
por: Githinji, George, et al.
Publicado: (2021)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
por: Nyagwange, James, et al.
Publicado: (2022)

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study
por: Agoti, Charles N, et al.
Publicado: (2022)

Examining health facility financing in Kenya in the context of devolution
por: Kairu, Angela, et al.
Publicado: (2021)

The autonomy of public health facilities in decentralised contexts: insights from applying a complexity lens in Kenya
por: Barasa, Edwine, et al.
Publicado: (2022)

Modelling the cost-effectiveness of essential and advanced critical care for COVID-19 patients in Kenya
por: Kairu, Angela, et al.
Publicado: (2021)

Impact of free maternity policies in Kenya: an interrupted time-series analysis
por: Orangi, Stacey, et al.
Publicado: (2021)

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
por: Otiende, M., et al.
Publicado: (2023)

Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya
por: Orangi, Stacey, et al.
Publicado: (2021)

Examining the implementation of the Linda Mama free maternity program in Kenya
por: Orangi, Stacey, et al.
Publicado: (2021)

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
por: Briones, Jamaica, et al.
Publicado: (2022)

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
por: Gallagher, Katherine E., et al.
Publicado: (2023)

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
por: Ojal, John, et al.
Publicado: (2019)

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
por: Nyagwange, James, et al.
Publicado: (2023)

The impact of COVID-19 on health financing in Kenya
por: Kairu, Angela, et al.
Publicado: (2023)

Exploring the Adaptations of the Free Maternity Policy Implementation by Health Workers and County Officials in Kenya
por: Oyugi, Boniface, et al.
Publicado: (2023)

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March–May 2023
por: Mwanga, Mike J., et al.
Publicado: (2023)

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data
por: Ojal, John, et al.
Publicado: (2017)

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
por: Bottomley, C., et al.
Publicado: (2021)

Tackling health professionals’ strikes: an essential part of health system strengthening in Kenya
por: Irimu, Grace, et al.
Publicado: (2018)

The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria
por: Adamu, Aishatu Lawal, et al.
Publicado: (2022)

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
por: Flasche, Stefan, et al.
Publicado: (2020)

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population
por: Ochola-Oyier, Lynette Isabella, et al.
Publicado: (2016)

Transmission and Age Impact the Risk of Developing Febrile Malaria in Children with Asymptomatic Plasmodium falciparum Parasitemia
por: Wamae, Kevin, et al.
Publicado: (2019)

Telling our own story in global health–experience from Nigeria
por: Ihekweazu, Chikwe, et al.
Publicado: (2022)

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
por: Ndwiga, Leonard, et al.
Publicado: (2021)

Crude childhood vaccination coverage in West Africa: Trends and predictors of completeness
por: Kazungu, Jacob S., et al.
Publicado: (2017)

Implications from predicted B-cell and T-cell epitopes of Plasmodium falciparum merozoite proteins EBA175-RII and Rh5
por: Wamae, Kevin Kariuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dm38tf8sjbqb4hhi9s2kje90hq